netFormulary The Rotherham NHS
NHS Foundation Trust  
 Search
 Formulary Chapter 4: Central nervous system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
04.01 Hypnotics and anxiolytics (0,0)
04.01.01 Hypnotics (1,0)
Benzodiazepines (2,0)
Zaleplon, Zolpidem and Zopiclone (3,0)
Chloral and derivatives (2,0)
Clomethiazole (Chlormethiazole) (1,0)
Antihistamines (1,0)
Alcohol (0,0)
Sodium oxybate (0,0)
04.01.02 Anxiolytics (0,0)
Benzodiazepines (4,0)
Buspirone (1,0)
Beta blockers (0,0)
Meprobamate (0,0)
04.01.03 Barbiturates (1,0)
04.02 Drugs used in psychoses and related disorders (0,0)
04.02.01 Antipsychotic Drugs (13,0)
Second-Generation Antipsychotic Drugs (6,0)
04.02.02 Antipsychotic depot injections (11,0)
04.02.03 Antimanic drugs (2,0)
Benzodiazepines (1,0)
Antipsychotic drugs (0,0)
Carbamazepine (1,0)
Valproic acid (1,0)
Lithium (4,0)
04.03 Antidepressant drugs (0,0)
04.03.01 Tricyclic and related antidepressant drugs (0,0)
Tricyclic antidepressants (8,0)
Related antidepressants (2,0)
04.03.02 Monoamine-oxidase inhibitors (2,0)
Reverible MAOIs (1,0)
04.03.03 Selective serotonin re-uptake inhibitors (6,0)
04.03.04 Other antidepressant drugs (8,0)
04.04 CNS stimulants and other drugs used for attention deficit hyperactivity disorder (4,0)
Cocaine (0,0)
04.05 Drugs used in the treatment of obesity (0,0)
04.05.01 Anti-obesity drugs acting on the gastro-intestingal tract (0,0)
04.05.02 Centrally acting appetite suppressants (0,0)
04.06 Drugs used in nausea and vertigo (0,0)
Vomiting during pregnancy (0,0)
Postoperative nausea and vomiting (0,0)
Motion sickness (0,0)
Other vestibular disorders (0,0)
Cytotoxic chemotherapy (0,0)
Palliative care (0,0)
Migraine (0,0)
Antihistamines (3,0)
Phenothiazines and related drugs (6,0)
Domperidone and metoclopramide (2,0)
5HT3 antagonists (2,0)
Neurokinin receptor antagonist (1,0)
Cannabinoid (0,0)
Hyoscine (1,0)
Other drugs for Ménière's disease (1,0)
04.07 Analgesics (0,0)
04.07.01 Non-opioid analgesics and compound analgesic preparations (0,0)
Compound analgesic preparations (6,0)
04.07.02 Opioid analgesics (15,0)
04.07.03 Neuropathic pain (3,0)
Trigeminal neuralgia (2,0)
Postherpetic neuralgia (2,0)
Chronic facial pain (0,0)
04.07.04 Antimigraine drugs (0,0)
04.07.04.01 Treatment of the acute migraine attack (0,0)
Analgesics (0,0)
5HT1 agonists (2,0)
Ergot alkaloids (0,0)
Anti-emetics (0,0)
Other drugs for migrane (0,0)
04.07.04.02 Prophylaxis of migraine (6,0)
04.07.04.03 Cluster headache (1,0)
04.08 Antiepileptics (0,0)
04.08.01 Control of epilepsy (0,0)
Partial seizures with or without secondary generalisation (0,0)
Generalised seizures (0,0)
Carbamazepine and Oxcarbazepine (2,0)
Ethosuximide (2,0)
Gabapentin and pregabalin (2,0)
Lacosamide (0,0)
Lamotrigine (1,0)
Levetiracetam (1,0)
Phenobarbital and other barbiturates (2,0)
Phenytoin (1,0)
Retigaine (0,0)
Rufinamide (0,0)
Tiagabine (1,0)
Topiramate (1,0)
Valproate (1,0)
Vigabatrin (1,0)
Zonisamide (0,0)
Benzodiazepines (2,0)
Other Drugs (1,0)
04.08.02 Drugs used in status epilepticus (7,0)
04.08.03 Febrile convulsions (2,0)
04.09 Drugs used in parkinsonism and related disorders (0,0)
04.09.01 Dopaminergic drugs used in Parkinsons disease (0,0)
Dopamine receptor agonists (7,0)
Levodopa (6,0)
Monoamine-oxidase-B inhibitors (2,0)
Catachol-O-methyltransferase inhibitors (1,0)
Amantadine (1,0)
04.09.02 Antimuscarinic drugs used in parkinsonism (3,0)
04.09.03 Drugs used in essential tremor, chorea, tics, and related disorders (3,0)
Torsion dystonias and other involuntary movements (3,0)
04.10 Drugs used in substance dependence (0,0)
Alcohol dependence (0,0)
Cigarette smoking (0,0)
Opioid dependence (0,0)
04.10.01 Alcohol dependence (3,0)
04.10.02 Nicotine dependence (1,0)
04.10.03 Opioid dependence (0,0)
Opioid substitution therapy (2,0)
Adjunctive therapy and symptomatic treatment (1,0)
Opioid-receptor antagonists (1,0)
04.11 Drugs for dementia (4,0)
netFormulary